Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

Khoon Lin Ling; Ida Hilmi; Raja Affendi Raja Ali; Rupert W. L. Leong; Wai Keung Leung; Siew Chien Ng; Kai Chun Wu; Min Hu Chen; Zhi Hua Ran; Tadakazu Hisamatsu; Vineet Ahuja; Govind K. Makharia; Rupa Banerjee; Shu Chen Wei; Deng Chyang Wu; Pises Pisespongsa; Byong Duk Ye; Jose Sollano; Marcellus Simadibrata; Sai Wei Chuah; Choon Jin Ooi

doi:10.1002/jgh3.12362

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

Khoon Lin Ling, Ida Hilmi, Raja Affendi Raja Ali, Rupert W. L. Leong, Wai Keung Leung, Siew Chien Ng, Kai Chun Wu, Min Hu Chen, Zhi Hua Ran, Tadakazu Hisamatsu, Vineet Ahuja, Govind K. Makharia, Rupa Banerjee, Shu Chen Wei, Deng Chyang Wu, Pises Pisespongsa, Byong Duk Ye, Jose Sollano, Marcellus Simadibrata, Sai Wei ChuahChoon Jin Ooi^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

38 Downloads (Pure)

Abstract

The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy. In view of this, experts in IBD across the Asia Pacific region were invited to put together recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main principle of management. In addition, social distancing measures and the appropriate use of personal protective equipment should be strictly adhered to. During the current pandemic, face-to-face clinic follow ups and non-urgent procedures should be kept to a minimum.

Original language	English
Pages (from-to)	320-323
Number of pages	4
Journal	JGH Open
Volume	4
Issue number	3
DOIs	https://doi.org/10.1002/jgh3.12362
Publication status	Published - 5 Jun 2020
Externally published	Yes

Bibliographical note

Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

Keywords

COVID-19
Crohn's disease
inflammatory bowel diseases
ulcerative colitis

Access to Document

10.1002/jgh3.12362

Publisher version (open access)Final published version, 235 KBLicence: CC BY

Cite this

Ling, K. L., Hilmi, I., Raja Ali, R. A., Leong, R. W. L., Leung, W. K., Ng, S. C., Wu, K. C., Chen, M. H., Ran, Z. H., Hisamatsu, T., Ahuja, V., Makharia, G. K., Banerjee, R., Wei, S. C., Wu, D. C., Pisespongsa, P., Ye, B. D., Sollano, J., Simadibrata, M., ... Ooi, C. J. (2020). Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic. JGH Open, 4(3), 320-323. https://doi.org/10.1002/jgh3.12362

@article{b2f79c9a9b8c452e953e04e841981133,

title = "Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic",

abstract = "The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy. In view of this, experts in IBD across the Asia Pacific region were invited to put together recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main principle of management. In addition, social distancing measures and the appropriate use of personal protective equipment should be strictly adhered to. During the current pandemic, face-to-face clinic follow ups and non-urgent procedures should be kept to a minimum.",

keywords = "COVID-19, Crohn's disease, inflammatory bowel diseases, ulcerative colitis",

author = "Ling, {Khoon Lin} and Ida Hilmi and {Raja Ali}, {Raja Affendi} and Leong, {Rupert W. L.} and Leung, {Wai Keung} and Ng, {Siew Chien} and Wu, {Kai Chun} and Chen, {Min Hu} and Ran, {Zhi Hua} and Tadakazu Hisamatsu and Vineet Ahuja and Makharia, {Govind K.} and Rupa Banerjee and Wei, {Shu Chen} and Wu, {Deng Chyang} and Pises Pisespongsa and Ye, {Byong Duk} and Jose Sollano and Marcellus Simadibrata and Chuah, {Sai Wei} and Ooi, {Choon Jin}",

note = "Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.",

year = "2020",

month = jun,

day = "5",

doi = "10.1002/jgh3.12362",

language = "English",

volume = "4",

pages = "320--323",

journal = "JGH Open",

issn = "2397-9070",

publisher = "John Wiley & Sons",

number = "3",

}

Ling, KL, Hilmi, I, Raja Ali, RA, Leong, RWL, Leung, WK, Ng, SC, Wu, KC, Chen, MH, Ran, ZH, Hisamatsu, T, Ahuja, V, Makharia, GK, Banerjee, R, Wei, SC, Wu, DC, Pisespongsa, P, Ye, BD, Sollano, J, Simadibrata, M, Chuah, SW & Ooi, CJ 2020, 'Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic', JGH Open, vol. 4, no. 3, pp. 320-323. https://doi.org/10.1002/jgh3.12362

TY - JOUR

T1 - Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

AU - Ling, Khoon Lin

AU - Hilmi, Ida

AU - Raja Ali, Raja Affendi

AU - Leong, Rupert W. L.

AU - Leung, Wai Keung

AU - Ng, Siew Chien

AU - Wu, Kai Chun

AU - Chen, Min Hu

AU - Ran, Zhi Hua

AU - Hisamatsu, Tadakazu

AU - Ahuja, Vineet

AU - Makharia, Govind K.

AU - Banerjee, Rupa

AU - Wei, Shu Chen

AU - Wu, Deng Chyang

AU - Pisespongsa, Pises

AU - Ye, Byong Duk

AU - Sollano, Jose

AU - Simadibrata, Marcellus

AU - Chuah, Sai Wei

AU - Ooi, Choon Jin

N1 - Copyright the Author(s) 2020. Version archived for private and non-commercial use with the permission of the author/s and according to publisher conditions. For further rights please contact the publisher.

PY - 2020/6/5

Y1 - 2020/6/5

N2 - The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy. In view of this, experts in IBD across the Asia Pacific region were invited to put together recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main principle of management. In addition, social distancing measures and the appropriate use of personal protective equipment should be strictly adhered to. During the current pandemic, face-to-face clinic follow ups and non-urgent procedures should be kept to a minimum.

AB - The COVID-19 pandemic, secondary to SARS-CoV-2, has resulted in high mortality and morbidity worldwide. As inflammatory bowel disease (IBD) is a chronic disease, and most patients are on long-term immunosuppressive agents, there is understandable concern, particularly in terms of therapy. In view of this, experts in IBD across the Asia Pacific region were invited to put together recommendations based on their experience and the currently available data. In general, most IBD therapies (with a few exceptions) can be continued safely, and the general consensus is that maintaining disease control should remain the main principle of management. In addition, social distancing measures and the appropriate use of personal protective equipment should be strictly adhered to. During the current pandemic, face-to-face clinic follow ups and non-urgent procedures should be kept to a minimum.

KW - COVID-19

KW - Crohn's disease

KW - inflammatory bowel diseases

KW - ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=85085969508&partnerID=8YFLogxK

U2 - 10.1002/jgh3.12362

DO - 10.1002/jgh3.12362

M3 - Article

C2 - 32514431

AN - SCOPUS:85085969508

SN - 2397-9070

VL - 4

SP - 320

EP - 323

JO - JGH Open

JF - JGH Open

IS - 3

ER -

Asian Pacific Association of Gastroenterology (APAGE) Inflammatory Bowel Disease (IBD) Working Party guidelines on IBD management during the COVID-19 pandemic

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this